Antimicrobial Susceptibility Testing Market Report
Global Antimicrobial Susceptibility Testing Market, By Product (Automated Laboratory Instruments, Manual Antimicrobial Susceptibility Testing Products, Culture and Growth Media, And Consumables); By Application (Clinical Diagnostics, Drug Discovery, and Development, Epidemiology, Other Applications); By Type (Antifungal Susceptibility Testing, Antibacterial Susceptibility Testing, Antiparasitic Susceptibility Testing, Other Susceptibility Testing Types); By Method (Disk Diffusion, ETEST Method, Automated Susceptibility Testing Instruments, Agar Dilution, Genotyping Methods) By End-User (Hospitals and Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, Clinical Research Organizations (CROs)); By Region (North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America) Trend Analysis, Competitive Market Share & Forecast, 2017-2027
- Published Date: June 2021
- Report ID: bwc20388
- Available Format: PDF
- Page: 156
Report Overview
The Global Antimicrobial
Susceptibility Testing Market- Industry Trends & Forecast Report 2027
The global antimicrobial susceptibility testing market was worth USD 3.19 billion in 2020 and is further projected to reach a valuation of USD 4.70 billion by 2027, at a CAGR of 5.9% during the forecast period (2021-2027). Antimicrobial resistance to bacterial infections, driven by an increase in resistant bacterial strains and antibiotic usage, is driving the global antimicrobial susceptibility testing market. The market is also gaining momentum due to the growing incorporation of rapid commercial AST (Antimicrobial Susceptibility Testing) systems to test fungal infections. Other significant factors like increased funding and government initiatives, surge in the incidences of infectious diseases globally, and the emergence of multidrug-resistant bacterial strains like Acinetobacter baumannii, MRSA, and Klebsiella pneumonia are considerably boosting the growth of the global antimicrobial susceptibility testing market.
Source: Blue Weave Consulting
Global Antimicrobial Susceptibility
Testing Market Overview
Antimicrobial susceptibility
testing or AST is a procedure performed under laboratory conditions to confirm
the specific antibiotic regimen suitable for a particular patient, based on the
type of infection and the bacterial strain infecting the patient. Thus, by
performing this test, one can determine the sensitivity of a microbe to any
particular antibiotic. An essential guideline in successful treatment has been
the avoidance of over-medication with paradoxical worsening. Higher antibiotics
like carbapenem, glycopeptide, oxazolidinone are usually reserved for the
treatment of more severe infections. Instead, they are the "last
line" agents to be used (Duplessis C, Cianflone N, 2011). Thus, to
determine the infection and its suitable antibiotic regimen, the global
antimicrobial susceptibility testing market is proliferating.
Global Antimicrobial Susceptibility
Testing Market Trend
Growth Drivers
Growing Prevalence of
Multidrug-Resistant Bacterial Strains
Human health is at risk as a
result of the emergence of resistance to the most common bacterial diseases. The
emergence of multidrug-resistant organisms in the hospital environment and
community settings suggests that reservoirs of antibiotic-resistant bacteria
are present even outside the hospital. Most antimicrobial agents are naturally produced
molecules, and so co-resident bacteria have evolved mechanisms to overcome
their action to survive. Thus, these organisms are often considered to be
"intrinsically" resistant to one or more antimicrobial agents. Antibiotic
resistance is among the three most important public health threats of the 21st
century, as recommended by World Health Organization.
Antibiotic-resistant
bacteria are an essentially unavoidable result of widespread antimicrobial
usage, resulting in increased demand for the development of newer medications
and antimicrobial susceptibility testing. Thus, due to such a significant
threat, antimicrobial susceptibility testing has become imperative to treat
microbial infection, to prevent paradoxical worsening of the patient's
condition due to over-medication or under-medication. Antimicrobial
susceptibility testing also plays a vital role in research to find out the
multidrug-resistant strains and find the most effective therapeutic regimen for
its treatment. Hence owing to this, the global antimicrobial susceptibility
market is growing exponentially.
Increased Funding and Increasing Government
Initiatives
Governments of different countries have been taking
various measures to raise awareness regarding the effects of the overuse of
antimicrobial agents to treat microbial infections. These initiatives by
governments across the globe have been helpful in providing critical
information to patients, doctors, and nurses about the prevention of the
incidences of diseases. India, for example, launched the National Programme on
Containment of Antimicrobial Resistance (2012-2017) in the country as part of
its 12th five-year plan to establish a laboratory-based antimicrobial resistance
(AR) surveillance system to raise awareness among healthcare providers about
antimicrobial resistance. Such initiatives have been propelling the growth of
the global antimicrobial susceptibility testing market.
Restraints
High Cost Involved in Automated Antimicrobial
Susceptibility Testing Instruments
Because they have greatly expanded features and
functionalities, automated antimicrobial susceptibility testing devices are
quite costly and offered at premium rates. In comparison to manual antimicrobial
testing approaches such as the disc diffusion technique, which requires
manually inserting antibiotic-soaked discs on microbial-infected agar plates,
the deployment of automated AST systems takes substantially less time. These
automated testing kits reduce incubation time since they comprise cutting-edge
techniques that mimic the environmental conditions of the host body for
microbial growth. However, these improved technologies have a relatively high
investment cost, which is a major impediment to their deployment, particularly
for small-budget organizations.
Impact of COVID-19
Because to the COVID-19
epidemic, several industries have been caught off guard, and the global
antimicrobial susceptibility testing market is no exceptionBillion. Because
hospitals focused primarily on COVID -19 management at the start of the
pandemic, the utilization of automated antimicrobial susceptibility testing
devices such as the Accelerate Pheno system, MicroScan WalkAway, and Sensitive
ARIS system was significantly reduced. Moreover, all other procedures and
protocols were temporarily put on hold to focus on the COVID-19 pandemic and
check the spread of the virus. Furthermore, tight regulatory measures such as
lockdown and curfew had a negative impact on the global antimicrobial
susceptibility testing market.
Global Antimicrobial
Susceptibility Testing Market: By Product
The global antimicrobial
susceptibility testing industry is categorized into automated
laboratory instruments, culture and growth media, manual antimicrobial
susceptibility testing products, and consumables based on the type of
product. In the global antimicrobial susceptibility testing market, the manual
susceptibility testing products segment holds the largest share. Manual
antimicrobial susceptibility testing products comprise susceptibility testing
disks, MIC strips, and susceptibility testing plates. The growing prevalence of
antibacterial resistance, newer treatment protocols, affordability, and its
small-scale application are the major factors contributing to this segment's
growth.
Global Antimicrobial
Susceptibility Testing Market: By Application
In terms of application, the
global antimicrobial susceptibility testing market is segmented into clinical diagnostics,
epidemiology, drug discovery & development, and other applications. Out of these,
the clinical diagnostics segment accounted for the largest share of the global
antimicrobial susceptibility testing market. The massive share can be attributed
to the growing incidence of HAIs (Hospital-acquired infections), increasing
cases of infectious diseases, and large target patient population volume, coupled
with the early disease diagnosis across significant markets. The rising procedural
volume of clinical diagnostic tests and the introduction of various
technologically advanced susceptibility testing products also contribute to the
market growth.
Global Antimicrobial
Susceptibility Testing Market: By Type
Based on type, the global
antimicrobial susceptibility testing market is segmented into antibacterial susceptibility testing, antiparasitic
susceptibility testing, antifungal susceptibility testing, other susceptibility
testing types. The antibacterial
susceptibility testing segment holds the largest share in the global
antimicrobial susceptibility testing market. The significant share of this
segment can be attributed to the emergence of multidrug-resistant strains like Klebsiella
pneumonia, Acinetobacter baumanii. S. aureus, MRSA. These
are some highly resistant bacteria that have developed severe resistance due to
genetic mutations, which has led to the development of resistant systems, like
the efflux pump system, which effectively shields the bacteria from antibiotic
attacks.
Global Antimicrobial
Susceptibility Testing Market: By Method
Based on method, the global
antimicrobial susceptibility testing market is segmented into
disk diffusion, agar dilution, automated susceptibility testing instruments, genotyping
methods. Out of these methods, the automated antimicrobial
susceptibility testing instruments segment accounts for the largest share in
the global antimicrobial susceptibility testing market. The segment's dominance
can be attributed to crucial aspects such as accuracy, precision, and
shortened time due to the absence of any incubation period. Moreover, it
has the ability to simultaneously produce qualitative and quantitative
susceptibility results. Also, technological enhancements and increasing
investments in R&D by key players to deliver novel technologies are equally
contributing to the growth of this segment.
Global Antimicrobial Susceptibility
Testing Market: By Region
Based on type, the global antimicrobial susceptibility testing market is segmented into North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America. Out of these regions, North America holds the lion’s share of the global antimicrobial susceptibility testing market. The growing investment in R&D to develop novel automated AST systems, technological advancements in antimicrobial susceptibility products, increasing cases of infectious diseases are some of the key factors supporting market growth in North America.
Source: Blue Weave Consulting
Competitive Landscape
The growing prevalence of
infectious diseases, coupled with emerging multidrug-resistant bacterial
strains and growing government initiatives, have made the global antimicrobial
susceptibility testing market a very lucrative one. Stiff competition is present
within the key players to develop better testing solutions for more accurate
and quicker results to satisfy the end-users. Some of the major companies in
the global antimicrobial susceptibility testing market are- PML
Microbiologicals Inc., BioMérieux SA, QuantaMatrix Inc., MP Biomedicals, InvivoGen,
Biotron Ltd, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher
Corporation, Roche Diagnostics Limited, Bio-Rad Laboratories, Inc., Merck KGaA,
Accelerate Diagnostics, Inc., Liofilchem S.r.l., ZHUHAI DL BIOTECH Co., Ltd., ELITechGroup,
Halifax S.r.l., Hi-Media Laboratories, Genefluidics, Inc., Creative Diagnostics,
and other prominent players.
Recent Developments
·
In March 2021, bioMérieux announced
the launch of VIDAS TB-IGRA,
which is the new fully automated assay intended to aid in the diagnosis of Mycobacterium
tuberculosis infection. VIDAS TB-IGRA provides reliable test
results and improves current workflow.
·
In May 2020, Liofilchem received the US FDA
approval for the Lefamulin 0.016-256 μg/mL MTS (MIC Test Strip), a quantitative
assay to be used to determine the minimum inhibitory concentration (MIC) of
lefamulin.
Attribute |
Details |
Years Considered |
Historical data –
2017-2020 Base Year – 2020 Forecast
– 2021 – 2027 |
Facts Covered |
Revenue
in USD Million |
Market Coverage |
U.S,
Canada, Germany, UK, France, Italy, Spain, Brazil, Japan, South Korea, China,
India, UAE, South Africa, Saudi Arabia |
Product/Service Segmentation |
By Type, By The Method, By
Application, By Product, By End-User, By Region |
Key Players |
PML Microbiologicals Inc., BioMérieux SA, QuantaMatrix
Inc., MP Biomedicals, InvivoGen, Biotron Ltd, Becton, Dickinson and Company, Thermo
Fisher Scientific, Danaher Corporation, Roche Diagnostics Limited, Bio-Rad
Laboratories, Inc., Merck KGaA, Accelerate Diagnostics, Inc., Liofilchem
S.r.l., ZHUHAI DL BIOTECH Co., Ltd., ELITechGroup, Halifax S.r.l., Hi-Media
Laboratories, Genefluidics, Inc., Creative Diagnostics.
|
·
By Product
o Manual
Antimicrobial Susceptibility Testing Products
§ Susceptibility
Testing Disks
§ MIC
Strips
§ Susceptibility
Testing Plates
o Automated
Laboratory Instruments
o Culture
and Growth Media
o Consumables
·
By Application
o Clinical
Diagnostics
o Drug
Discovery and Development
o Epidemiology
o Other
Applications
·
By End-User
o
Hospitals and Diagnostic Centers
o
Pharmaceutical and Biotechnology Companies
o
Research &Academic Institutes
o
Clinical Research Organizations (CROs)
·
By Type
o
Antibacterial Susceptibility Testing
o
Antifungal Susceptibility Testing
o
Antiparasitic Susceptibility Testing
o
Other Susceptibility Testing Types (slow-growing pathogens)
·
By Method
o
Test Method
o
Disk Diffusion
o
Automated Susceptibility Testing Instruments
o
Agar Dilution
o
Genotyping Methods
·
By Region
o
North America
o
Europe
o
The Asia-Pacific
o
Latin America
o
The Middle East and Africa
FAQs:
1. What is the current size of the global antimicrobial
susceptibility testing market?
Answer: The global antimicrobial
susceptibility testing market reached USD XX billion in 2020.
2. What are the major factors driving the growth of the global
antimicrobial susceptibility testing market?
Answer: The
growing prevalence of infectious diseases, coupled with emerging
multidrug-resistant bacterial strains and growing government initiatives, has
made the global antimicrobial susceptibility testing market a very lucrative
one.
3. Who are the key players in the global antimicrobial
susceptibility testing market?
Answer: PML
Microbiologicals Inc., BioMérieux SA, QuantaMatrix Inc., MP Biomedicals, InvivoGen,
Biotron Ltd, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher
Corporation, Roche Diagnostics Limited, Bio-Rad Laboratories, Inc., Merck KGaA,
Accelerate Diagnostics, Inc., Liofilchem S.r.l., ZHUHAI DL BIOTECH Co., Ltd., ELITechGroup,
Halifax S.r.l., Hi-Media Laboratories, Genefluidics, Inc., Creative Diagnostics.
4. Which application accounted for the largest share in
the global antimicrobial susceptibility testing market?
Answer: Clinical Diagnostics by
application accounted for the largest share in the global antimicrobial
susceptibility testing market.
5. Which region is growing at a higher rate in the global
antimicrobial susceptibility testing market?
Answer: North America is growing at a higher rate in the global antimicrobial susceptibility testing market.
1.
Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2.
Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data
Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research
Respondents, By Region
2.5. Assumption & Limitation
3.
Executive Summary
4. Global Antimicrobial
Susceptibility Testing Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Recent Development/Technological
Advancements
4.4. Porter’s Five Forces Analysis
4.4.1. Bargaining Application of
Suppliers
4.4.2. Bargaining Application of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Intensity of Rivalry
5.
Global Antimicrobial Susceptibility Testing Market Overview
5.1. Market Size & Forecast by
Value, 2017-2027
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.1.1.
Manual Antimicrobial Susceptibility Testing
Products
5.2.1.1.1.
Susceptibility Testing Disks
5.2.1.1.2.
MIC Strips
5.2.1.1.3.
Susceptibility Testing Plates
5.2.1.2.
Automated Laboratory Instruments
5.2.1.3.
Culture and Growth Media
5.2.1.4.
Consumables
5.2.2. By Application
5.2.2.1.
Clinical Diagnostics
5.2.2.2.
Drug Discovery and Development
5.2.2.3.
Epidemiology
5.2.2.4.
Other Applications
5.2.3. By End-User
5.2.3.1.
Hospitals and Diagnostic Centers
5.2.3.2.
Pharmaceutical and Biotechnology Companies
5.2.3.3.
Research &Academic Institutes
5.2.3.4.
Clinical Research Organizations (CROs)
5.2.4.
By Type
5.2.4.1.
Antibacterial Susceptibility Testing
5.2.4.2.
Antifungal Susceptibility Testing
5.2.4.3.
Antiparasitic Susceptibility Testing
5.2.4.4.
Other Susceptibility Testing Types (slow-growing pathogens)
5.2.5.
By Method
5.2.5.1.
Etest Method
5.2.5.2.
Disk Diffusion
5.2.5.3.
Automated Susceptibility Testing Instruments
5.2.5.4.
Agar Dilution
5.2.5.5.
Genotyping Methods
5.2.6. By Region
5.2.6.1.
North America
5.2.6.2.
Europe
5.2.6.3.
the Asia-Pacific
5.2.6.4.
Latin America
5.2.6.5.
the Middle East and Africa
6.
North America Antimicrobial Susceptibility Testing Market
6.1.
Market Size &
Forecast by Value, 2017-2027
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By End-User
6.2.4. By Type
6.2.5. By Method
6.2.6. By Country
6.2.6.1.
U.S.
6.2.6.2.
Canada
7.
Europe Antimicrobial
Susceptibility Testing Market
7.1. Market Size & Forecast by
Value, 2017-2027
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By End-User
7.2.4. By Type
7.2.5. By Method
7.2.6. By Country
7.2.6.1.
Germany
7.2.6.2.
United Kingdom
7.2.6.3.
Italy
7.2.6.4.
France
7.2.6.5.
Spain
7.2.6.6.
Rest of Europe
8.
the Asia-Pacific Antimicrobial
Susceptibility Testing Market
8.1. Market Size & Forecast by
Value, 2017-2027
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Type
8.2.5. By Method
8.2.6. By Country
8.2.6.1.
China
8.2.6.2.
India
8.2.6.3.
Japan
8.2.6.4.
Singapore
8.2.6.5.
South Korea
8.2.6.6.
Rest of Asia Pacific
9.
Latin America Antimicrobial Susceptibility Testing Market
9.1. Market Size & Forecast by
Value, 2017-2027
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By End-User
9.2.4. By Type
9.2.5. By Method
9.2.6. By Country
9.2.6.1.
Brazil
9.2.6.2.
Argentina
9.2.6.3.
Columbia
9.2.6.4.
Mexico
9.2.6.5.
Rest of Latin America
10.the Middle East & Africa Antimicrobial Susceptibility Testing Market
10.1. Market Size & Forecast by
Value, 2017-2027
10.1.1.
By Value (USD Million)
10.2. Market Share & Forecast
10.2.1.
By Product
10.2.2.
By Application
10.2.3.
By End-User
10.2.4.
By Type
10.2.5.
By Method
10.2.6.
By Country
10.2.6.1.
Saudi Arabia
10.2.6.2.
Iran
10.2.6.3.
UAE
10.2.6.4.
Turkey
10.2.6.5.
South Africa
10.2.6.6.
Rest of The Middle East & Africa
11.Competitive Landscape
11.1.
List of Key Players and Their Offerings
11.2.
Market Share Analysis, 2020
11.3.
Competitive Benchmarking, By Operating
Parameters
12.Impact of Covid-19 on Global Antimicrobial Susceptibility Testing Industry
13.Company Profile (Company
Overview, Financial Matrix, Competitive landscape, Key Personnel, Key
Competitors, SWOT Analysis, Contact Address, and Strategic Outlook) **
13.1.
PML Microbiologicals Inc.
13.2.
BioMérieux SA
13.3.
QuantaMatrix Inc.
13.4.
MP Biomedicals
13.5.
InvivoGen
13.6.
Biotron Ltd
13.7.
Becton, Dickinson and
Company
13.8.
Thermo Fisher Scientific
13.9.
Danaher Corporation
13.10.
Roche Diagnostics Limited
13.11.
Bio-Rad Laboratories, Inc.
13.12.
Merck KGaA
13.13.
Accelerate Diagnostics,
Inc.
13.14.
Liofilchem S.r.l.
13.15.
ZHUHAI DL BIOTECH Co., Ltd.
13.16.
ELITechGroup
13.17.
Alifax
S.r.l.
13.18.
Hi-Media
Laboratories
13.19.
Genefluidics,
Inc.
13.20.
Creative
Diagnostics
14.Key Strategic Recommendations
*Financial details of
unlisted companies will be available as per data availability in final
deliverable
**The segmentation and the
companies are subjected to modifications based on in-depth secondary for the
final deliverable
List of Figures
Fig: Global Antimicrobial Susceptibility
Testing Segmentation
Fig: Global Antimicrobial Susceptibility
Testing Market Value Chain Analysis
Fig: Company Market Share Analysis, 2019
Fig: Global Antimicrobial Susceptibility
Testing Market Size, By Value (USD Billion), 2017-2027
Fig: Global Antimicrobial Susceptibility
Testing Market Share, By Product, By Value, 2017-2027
Fig: Global Antimicrobial Susceptibility
Testing Market Share, By Application, By Value, 2017-2021
Fig: Global Antimicrobial Susceptibility
Testing Market Share, By End-User, By Value, 2017-2027
Fig: Global Antimicrobial Susceptibility
Testing Market Share, By Type, By Value, 2017-2027
Fig: Global Antimicrobial Susceptibility
Testing Market Share, By Method, By Value, 2017-2027
Fig: Global Antimicrobial Susceptibility
Testing Market Share, By Region, By Value, 2017-2027
Fig: North America Antimicrobial
Susceptibility Testing Market Size, By Value (USD Billion), 2017-2027
Fig: North America Antimicrobial
Susceptibility Testing Market Share, By Product, By Value, 2017-2027
Fig: North America Antimicrobial
Susceptibility Testing Market Share, By Application, By Value, 2017-2027
Fig: North America Antimicrobial
Susceptibility Testing Market Share, By End-User, By Value, 2017-2027
Fig: North America Antimicrobial
Susceptibility Testing Market Share, By Type, By Value, 2017-2027
Fig: North America Antimicrobial
Susceptibility Testing Market Share, By Method, By Value, 2017-2027
Fig: North America Antimicrobial
Susceptibility Testing Market Share, By Country, By Value, 2017-2027
Fig: Europe Antimicrobial Susceptibility
Testing Market Size, By Value (USD Billion), 2017-2027
Fig: Europe Antimicrobial Susceptibility
Testing Market Share, By Product, By Value, 2017-2027
Fig: Europe Antimicrobial Susceptibility
Testing Market Share, By Application, By Value, 2017-2027
Fig: Europe Antimicrobial Susceptibility
Testing Market Share, By End-User, By Value, 2017-2027
Fig: Europe Antimicrobial Susceptibility
Testing Market Share, By Type, By Value, 2017-2027
Fig: Europe Antimicrobial Susceptibility
Testing Market Share, By Method, By Value, 2017-2027
Fig: Europe Antimicrobial Susceptibility
Testing Market Share, By Country, By Value, 2017-2027
Fig: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Size, By Value (USD Billion), 2017-2027
Fig: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Share, By Product, By Value, 2017-2021
Fig: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Share, By Application, By Value, 2017-2027
Fig: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Share, By End-User, By Value, 2017-2027
Fig: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Share, By Type, By Value, 2017-2027
Fig: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Share, By Method, By Value, 2017-2027
Fig: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Share, By Country, By Value, 2017-2027
Fig: Latin America Antimicrobial
Susceptibility Testing Market Size, By Value (USD Billion), 2017-2027
Fig: Latin America Antimicrobial
Susceptibility Testing Market Share, By Product, By Value, 2017-2027
Fig: Latin America Antimicrobial
Susceptibility Testing Market Share, By Application, By Value, 2017-2027
Fig: Latin America Antimicrobial
Susceptibility Testing Market Share, By End-User, By Value, 2017-2027
Fig: Latin America Antimicrobial
Susceptibility Testing Market Share, By Type, By Value, 2017-2027
Fig: Latin America Antimicrobial
Susceptibility Testing Market Share, By Method, By Value, 2017-2027
Fig: Latin America Antimicrobial
Susceptibility Testing Market Share, By Country, By Value, 2017-2027
Fig: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Size, By Value (USD Billion),
2017-2021
Fig: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Share, By Product, By Value,
2017-2027
Fig: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Share, By Application, By Value,
2017-2027
Fig: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Share, By End-User, By Value,
2017-2027
Fig: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Share, By Type, By Value, 2017-2027
Fig: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Share, By Method, By Value,
2017-2027
Fig: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Share, By Country, By Value,
2017-2027
List of Tables
Table: Global Antimicrobial
Susceptibility Testing Market Size, By Product, By Value, 2017-2027
Table: Global Antimicrobial
Susceptibility Testing Market Size, By Application, By Value, 2017-2027
Table: Global Antimicrobial
Susceptibility Testing Market Size, By End-User, By Value, 2017-2027
Table: Global Antimicrobial
Susceptibility Testing Market Size, By Type, By Value, 2017-2027
Table: Global Antimicrobial
Susceptibility Testing Market Size, By Method, By Value, 2017-2027
Table: Global Antimicrobial Susceptibility
Testing Market Size, By Region, By Value, 2017-2027
Table: North America Antimicrobial
Susceptibility Testing Market Size, By Product, By Value, 2017-2027
Table: North America Antimicrobial
Susceptibility Testing Market Size, By Application, By Value, 2017-2027
Table: North America Antimicrobial
Susceptibility Testing Market Size, By End-User, By Value, 2017-2027
Table: North America Antimicrobial
Susceptibility Testing Market Size, By Type, By Value, 2017-2027
Table: North America Antimicrobial Susceptibility
Testing Market Size, By Method, By Value, 2017-2027
Table: North America Antimicrobial
Susceptibility Testing Market Size, By Country, By Value, 2017-2027
Table: Europe Antimicrobial
Susceptibility Testing Market Size, By Product, By Value, 2017-2027
Table: Europe Antimicrobial
Susceptibility Testing Market Size, By Application, By Value, 2017-2027
Table: Europe Antimicrobial
Susceptibility Testing Market Size, By End-User, By Value, 2017-2027
Table: Europe Antimicrobial
Susceptibility Testing Market Size, By Type, By Value, 2017-2027
Table: Europe Antimicrobial
Susceptibility Testing Market Size, By Method, By Value, 2017-2027
Table: Europe Antimicrobial
Susceptibility Testing Market Size, By Country, By Value, 2017-2027
Table: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Size, By Product, By Value, 2017-2027
Table: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Size, By Application, By Value, 2017-2027
Table: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Size, By End-User, By Value, 2017-2027
Table: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Size, By Type, By Value, 2017-2027
Table: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Size, By Method, By Value, 2017-2027
Table: The Asia-Pacific Antimicrobial
Susceptibility Testing Market Size, By Country, By Value, 2017-2027
Table: Latin America Antimicrobial
Susceptibility Testing Market Size, By Product, By Value, 2017-2027
Table: Latin America Antimicrobial
Susceptibility Testing Market Size, By Application, By Value, 2017-2027
Table: Latin America Antimicrobial
Susceptibility Testing Market Size, By End-User, By Value, 2017-2027
Table: Latin America Antimicrobial
Susceptibility Testing Market Size, By Type, By Value, 2017-2027
Table: Latin America Antimicrobial
Susceptibility Testing Market Size, By Method, By Value, 2017-2027
Table: Latin America Antimicrobial
Susceptibility Testing Market Size, By Country, By Value, 2017-2027
Table: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Size, By Product, By Value,
2017-2027
Table: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Size, By Application, By Value,
2017-2027
Table: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Size, By End-User, By Value,
2017-2027
Table: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Size, By Type, By Value, 2017-2027
Table: The Middle East & Africa Antimicrobial
Susceptibility Testing Market Size, By Method, By Value, 2017-2027
Table: The Middle East & Africa
Antimicrobial Susceptibility Testing Market Size, By Country, By Value,
2017-2027
Table: PML Microbiologicals Inc.
Financial Analysis
Table: PML Microbiologicals Inc. Business
Overview
Table: BioMérieux SA Financial Analysis
Table: BioMérieux SA Business Overview
Table: QuantaMatrix Inc. Financial
Analysis
Table: QuantaMatrix Inc. Business
Overview
Table: MP Biomedicals Financial Analysis
Table: MP Biomedicals Business Overview
Table: InvivoGen Financial Analysis
Table: InvivoGen Business Overview
Table: Biotron Ltd Financial Analysis
Table: Biotron Ltd Business Overview
Table: Becton, Dickinson and Company
Financial Analysis
Table: Becton, Dickinson and Company
Business Overview
Table: Thermo Fisher Scientific
Financial Analysis
Table: Thermo Fisher Scientific Business
Overview
Table: Danaher Corporation Financial
Analysis
Table: Danaher Corporation Business
Overview
Table: Roche Diagnostics Limited Financial
Analysis
Table: Roche Diagnostics Limited
Business Overview
Table: Bio-Rad Laboratories, Inc.
Financial Analysis
Table: Bio-Rad Laboratories, Inc.
Business Overview
Table: Merck KGaA Financial Analysis
Table: Merck KGaA Business Overview
Table: Accelerate Diagnostics, Inc.
Financial Analysis
Table: Accelerate Diagnostics, Inc.
Business Overview
Table: Liofilchem S.r.l. Financial
Analysis
Table: Liofilchem S.r.l. Business
Overview
Table: ZHUHAI DL BIOTECH Co., Ltd. Financial Analysis
Table: ZHUHAI DL BIOTECH Co., Ltd. Business Overview
Table: ELITechGroup Financial Analysis
Table: ELITechGroup Business Overview
Table: Alifax S.r.l. Financial Analysis
Table: Alifax S.r.l. Business Overview
Table: Hi-Media Laboratories Financial
Analysis
Table: Hi-Media Laboratories Business
Overview
Table: Genefluidics, Inc. Financial
Analysis
Table: Genefluidics, Inc. Business
Overview
Table: Creative Diagnostics Financial
Analysis
Table: Creative Diagnostics Business
Overview
Market Segmentation
·
By Product
o Manual
Antimicrobial Susceptibility Testing Products
§ Susceptibility
Testing Disks
§ MIC
Strips
§ Susceptibility
Testing Plates
o Automated
Laboratory Instruments
o Culture
and Growth Media
o Consumables
·
By Application
o Clinical
Diagnostics
o Drug
Discovery and Development
o Epidemiology
o Other
Applications
·
By End-User
o
Hospitals and Diagnostic Centers
o
Pharmaceutical and Biotechnology Companies
o
Research &Academic Institutes
o
Clinical Research Organizations (CROs)
·
By Type
o
Antibacterial Susceptibility Testing
o
Antifungal Susceptibility Testing
o
Antiparasitic Susceptibility Testing
o
Other Susceptibility Testing Types (slow-growing pathogens)
·
By Method
o
Test Method
o
Disk Diffusion
o
Automated Susceptibility Testing Instruments
o
Agar Dilution
o
Genotyping Methods
·
By Region
o
North America
o
Europe
o
The Asia-Pacific
o
Latin America
o
The Middle East and Africa
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Coustom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.